TERN
NASDAQ · Pharmaceuticals
Terns Pharmaceuticals Inc
$52.86
+2.86 (+5.72%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-29.7% upside
Low Target
$32.00
Average Target
$37.17
High Target
$56.15
Current Price
$52.86
Current
$52.86
$52.86
Target
$37.17
$37.17
$32.00
$37.17 avg
$56.15
Scenario Analysis
Bear Case
$32.00
-39.5%
Low target
Base Case
$37.17
-29.7%
Avg target
Bull Case
$56.15
+6.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$48.26
9.5% from high
52-Week Low
$1.87
+2,734.3% from low
50-Day SMA
$38.73
+36.5% vs SMA
200-Day SMA
$16.20
+226.3% vs SMA
RSI (14)
69.0
Neutral
Target vs 52W High
$37.17
-23.0% vs high
Next Earnings Report
Mar 31, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.30
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |